Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01824511 · ClinicalTrials.gov registry record · NA

Effects of Quitting Study A Test of Pre-clinical Findings

A NA study, sponsored by University of Vermont.

Completed
Registry status
NA
Development phase
287
Enrollment target

NCT01824511 is a NA study that has completed, run by University of Vermont. The registered enrollment target is 287 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01824511, a NA study, has completed, sponsored by University of Vermont.

COMPLETED
Registry status
NA
Development phase
287 participants
Enrollment target

Study Summary

The most widely-accepted animal model of nicotine withdrawal states stopping nicotine makes rewarding events become less rewarding. The current study will test if this is true in humans. If we find tobacco abstinence does make rewards less rewarding, this would suggest new symptoms to add to official descriptions of nicotine withdrawal. It would also suggest we need to develop new behavioral and pharmacological interventions to correct this problem. If stopping smoking does not make rewards less rewarding, this would suggest this animal model does not apply to the human condition and we need to continue to search for an animal model of tobacco withdrawal that is relevant to smokers stopping smoking.

Interventions

  • BEHAVIORAL Smokers cease smoking

Trial Details

FieldValue
Enrollment Target 287 participants
Start Date 2013-04
Est. Completion 2015-09
Phase NA

Sponsor

University of Vermont

162 total trials

What the Registry Record Tells You About NCT01824511

The ClinicalTrials.gov registry entry for NCT01824511 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 287 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Vermont, which has 162 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Smokers cease smoking is the first listed.

NCT01824511 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01824511 about?

NCT01824511 is a clinical study titled "Effects of Quitting Study A Test of Pre-clinical Findings". The most widely-accepted animal model of nicotine withdrawal states stopping nicotine makes rewarding events become less rewarding. The current study will test if this is true in humans. If we find tobacco abstinence does make rewards less rewarding, this would suggest new symptoms to add to officia...

What is the current status of trial NCT01824511?

This trial is currently completed. It is a NA study. The enrollment target is 287 participants. The study started on 2013-04. Estimated completion is 2015-09.

What interventions are being tested in trial NCT01824511?

The interventions under investigation include: Smokers cease smoking (BEHAVIORAL).

Who is sponsoring clinical trial NCT01824511?

This trial is sponsored by University of Vermont, which has 162 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.